作者
Gilles Montalescot,Arnoud W.J. van ‘t Hof,Frédéric Lapostolle,Johanne Silvain,Jens Flensted Lassen,Leonardo Bolognese,Warren J. Cantor,Ángel Cequier,Mohamed Chettibi,Shaun G. Goodman,Christopher Hammett,Kurt Huber,Magnus Janzon,Béla Merkely,Robert F. Storey,Uwe Zeymer,Olivier Stibbe,Patrick Ecollan,Wim M.J.M. Heutz,Eva Swahn,Jean‐Philippe Collet,Frank F. Willems,Caroline Baradat,Muriel Licour,Anne Tsatsaris,Éric Vicaut,Christian W. Hamm
摘要
The direct-acting platelet P2Y12 receptor antagonist ticagrelor can reduce the incidence of major adverse cardiovascular events when administered at hospital admission to patients with ST-segment elevation myocardial infarction (STEMI). Whether prehospital administration of ticagrelor can improve coronary reperfusion and the clinical outcome is unknown.
xjcy
VDC
鬼见愁
精明的迎松
慕青
竹筏过海
杳鸢
xAnny
Zhenqian
xiaxiao
爱静静
独特觅翠
呆呆呆呆
MP
饱满的镜子
午见千山
香蕉觅云
平常的过客
jyy
CodeCraft
皖公网安备34019202002308
